Metformin may be used off-label to minimize COVID-19 symptoms and reduce Long COVID risk.
Only charged if approved
14-day supply + shipping
With RTHM discount
Paid to RTHM. Every 90 days, only if approved.
$4914-day fill + shipping
$5With RTHM discount
$54Metformin offers antiviral properties that help reduce the severity of acute COVID-19 symptoms, lowering viral loads and minimizing complications.
Metformin exhibits anti-inflammatory effects, potentially mitigating systemic inflammation characteristic of acute COVID-19 and Long COVID.
Research shows that metformin reduces the risk of Long COVID by up to 53% when taken within the first week of infection.
Metformin has been shown to help with:
Patients experiencing acute COVID-19 or at risk of Long COVID may find metformin a safe and effective preventive treatment option.
Metformin demonstrated antiviral properties in a study where participants treated with metformin during acute COVID-19 experienced a fourfold reduction in viral load compared to the placebo group.
Metformin exhibits anti-inflammatory properties that may mitigate systemic inflammation present in acute COVID-19 and Long COVID. These effects could reduce the severity of acute infections and the risk of Long COVID development.
Data presented at the 2024 Infectious Disease Week Annual Meeting revealed that metformin reduced the risk of Long COVID by 53% when prescribed within the first week of an acute SARS-CoV-2 infection.